Protective Effects of CYP2E1 Inhibitors on Metabolic Syndrome-induced Liver Injury in Guinea Pigs

References (49)

1. 1 Health effects of quercetin: From antioxidant to nutraceutical [DOI]
2. 2 A Comprehensive Review on Metabolic Syndrome [DOI]
3. 3 Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease [DOI]
4. 4 Mechanisms of Hepatotoxicity [DOI]
5. 5 Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy [DOI]
6. 6 Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects [DOI]
7. 7 Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease * [DOI]
8. 8 Cytochrome P-4502E1: its physiological and pathological role [DOI]
9. 9 Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. [DOI]
10. 10 Etiopathogenesis of Nonalcoholic Steatohepatitis [DOI]
11. 11 CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease [DOI]
12. 12 Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease [DOI]
13. 13 Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways [DOI]
14. 14 Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome [DOI]
15. 15 Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role [DOI]
16. 16 Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance [DOI]
17. 17 Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis [DOI]
18. 18 Metabolic syndrome and risk factors for non-alcoholic fatty liver disease [DOI]
19. 19 Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin Signaling [DOI]
20. 20 The epidemiology, pathogenesis and histopathology of fatty liver disease [DOI]
21. 21 Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1† [DOI]
22. 22 CYP2E1: from ASH to NASH [DOI]
23. 23 Clinics and research in hepatology and gastroenterology
24. 24 p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. [DOI]
25. 25 Inhibition of Ethanol-Induced Liver Disease in the Intragastric Feeding Rat Model by Chlormethiazole [DOI]
26. 26 Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression [DOI]
27. 27 Preferential effects of nicotine and 4-(N-methyl- N-nitrosamino)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase a4-4 induction and increased oxidative stress in the rat brain [DOI]
28. 28 Cytochrome P- 450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance [DOI]
29. 29 CYP2E1 Substrate Inhibition [DOI]
30. 30 Bariatric Surgery-Induced Weight Loss Reduces Hepatic Lipid Peroxidation Levels and Affects Hepatic Cytochrome P-450 Protein Content [DOI]
31. 31 The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage [DOI]
32. 32 Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease [DOI]
33. 33 Withdrawal: Hepatic manifestations of metabolic syndrome [DOI]
34. 34 Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
35. 35 Quercetin suppressed CYP2E1-dependent ethanol hepatotoxicity via depleting heme pool and releasing CO [DOI]
36. 36 Fomepizole in the treatment of acute methanol poisonings: Experience from the Czech mass methanol outbreak 2012-2013 [DOI]
37. 37 M1 Polarization Bias and Subsequent Nonalcoholic Steatohepatitis Progression Is Attenuated by Nitric Oxide Donor DETA NONOate via Inhibition of CYP2E1-Induced Oxidative Stress in Obese Mice [DOI]
38. 38 CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment [DOI]
39. 39 Induction of Rat Hepatic Cytochrome P450 Enzymes by Myristicin [DOI]
40. 40 Mechanism-Based Inactivation of Human CYP2E1 by Diethyldithocarbamate [DOI]
41. 41 Polyenylphosphatidylcholine Opposes the Increase of Cytochrome P‐4502E1 by Ethanol and Corrects Its Iron‐Induced Decrease [DOI]
42. 42 Cytochrome P450 expression and activities in rat, rabbit and bovine tongue [DOI]
43. 43 Inhibition of Ethanol‐Induced Liver Disease in the Intragastric Feeding Rat Model by Chlormethiazole [DOI]
44. 44 Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane. [DOI]
45. 45 Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity [DOI]
46. 46 Effect of 4-methylpyrazole on antioxidant enzyme status and lipid peroxidation in the liver of rats after exposure to ethylene glycol and ethyl alcohol [DOI]
47. 47 Use of Fomepizole in Pediatric Methanol Exposure: The First Case Report in Taiwan and a Literature Review [DOI]
48. 48 CYP2E1 substrate inhibition. MECHANISTIC INTERPRETATION THROUGH AN EFFECTOR SITE FOR MONOCYCLIC COMPOUNDS. [DOI]
49. 49 Polyenylphosphatidylcholine Opposes the Increase of Cytochrome P-4502E1 by Ethanol and Corrects Its Iron-Induced Decrease [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Metabolic Syndrome among Healthcare Workers in a Tertiary Hospital in South-South, Nigeria — shares topic coverage
• Cortisol and Metabolic Syndrome Components in Obese and Overweight Young Adults of a Nigerian Private University — shares topic coverage
• Metabolic Syndrome and Kidney Damage: Prevalence and Assessment of Risk among Apparently Healthy Resident of Ado Ekiti, South West Nigeria — shares topic coverage
• Vitamin D and Insulin Resistance in Metabolic Syndrome — shares topic coverage
• Metabolic Syndrome and Its Association with Nutritional and Cardiometabolic Risk Factors: Prevalence among Apparently Healthy Adults in a Rural Community in Southwestern Nigeria — shares topic coverage